[Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
Sign Up to like & getrecommendations! Published in 2022 at "Zhonghua wei zhong bing ji jiu yi xue"
DOI: 10.3760/cma.j.cn121430-20220701-00621
Abstract: OBJECTIVE To evaluate the safety and efficacy of argatroban applied as alternative anticoagulant in critical illness patients underwent extracorporeal membrane oxygenation (ECMO) with contraindications of unfractionated heparin (UFH), and to further explore the effective dose… read more here.
Keywords: ufh group; group; ecmo patients; argatroban group ... See more keywords